Learn about Boron Neutron Capture Therapy (BNCT), a highly promising cancer treatment modality

Boron Neutron Capture Therapy

Boron Neutron Capture Therapy (BNCT) is emerging as a hopeful method of curing cancer. It is a targeted radiation cancer therapy in which neutron beams destroy only boron compound-bearing tumors without destroying neighboring normal tissue. 

To learn more about this promising treatment modality and its clinical and industrial aspects, join our complimentary webinar on Wednesday, 2 March 2022, featuring world-renown experts:

Paul Busse, MD, PhD, Massachusetts General Hospital

Rob Hill, COO, TAE Life Sciences

Hanna Koivunoro, Chief Medical Physicist, Neutron Therapeutics

Thomas Rock Mackie, PhD, Emeritus Professor, University of Wisconsin Thomas Rock Mackie, PhD, Emeritus Professor, University of Wisconsin

Akira Matsumura, MD, PhD, Dr. med, University of Tsukuba Hospital Akira Matsumura, MD, PhD, Dr. med, University of Tsukuba Hospital

Toshinori Mitsumoto, Principle Engineer, Sumitomo Heavy Industries  Toshinori Mitsumoto, Principle Engineer, Sumitomo Heavy Industries

Seppo Pakala, Chief Medical Officer, Neutron Therapeutics

Elizabeth Reczek, PhD, CEO, Neutron Therapeutics Elizabeth Reczek, PhD, CEO, Neutron Therapeutics

Wolfgang Sauerwein, Prof. Dr. med, BNCT Global GmbH Wolfgang Sauerwein, Prof. Dr. med, BNCT Global GmbH

REGISTER NOW

Don’t miss out on a unique opportunity to get the latest information on:  

  • Current status of BNCT worldwide 
  • Ongoing clinical studies 
  • Recent BNCT drug development and use 
  • Comparison with conventional radiation therapy and proton therapy 
  • Role of imaging and patient positioning in BNCT 
  • Japan as a role model in BNCT 

Agenda

Unable to attend? Register anyway, and we’ll send you a link to the recording. 

REGISTER

BNCT

Webinar Host:

Cosylab is enabling BNCT companies to bring this hopeful method of curing cancer to everyday clinical practice and deliver better health care to patients worldwide. Cosylab is a proven partner with over two decades of experience solving complex software challenges in radiation therapy. OncologyOne, Cosylab’s software suite of medical-grade products, supports a growing number of clinical and technical advancements in BNCT. To learn more, visit https://radiotherapy.cosylab.com/.